Karine Breckpot
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
T cell senescence and exhaustion: molecular mechanisms and immune rejuvenation for cancer immunotherapy.
Journal: Signal transduction and targeted therapy
Published: November 03, 2025
Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
Journal: Oncoimmunology
Published: August 01, 2025
Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma.
Journal: Experimental hematology & oncology
Published: July 04, 2025
Preclinical development and selection of nanobody-based CAR-T cells targeting HER2-positive solid tumors.
Journal: Molecular therapy. Oncology
Published: June 11, 2025
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape.
Journal: Journal of hematology & oncology
Published: June 03, 2025
Immunopeptidomics identified antigens for mRNA-lipid nanoparticle vaccines with alpha-galactosylceramide in multiple myeloma therapy.
Journal: Journal for immunotherapy of cancer
Published: April 05, 2025
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways.
Journal: Cell reports
Published: March 24, 2025
An mRNA-based workflow validating neo-epitope presentation through HLA-I/peptide affinity purification.
Journal: Frontiers in immunology
Published: January 24, 2025
Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 16, 2025
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation.
Journal: Molecular therapy. Nucleic acids
Published: January 16, 2025
Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 18, 2024
Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity.
Journal: Journal for immunotherapy of cancer
Published: October 27, 2024
Last Updated: 09/26/2026